Semaglutide suitable for people with HIV and fatty liver disease
A study of persons with HIV (PWH) and metabolic dysfunction–associated steatotic liver disease, also known as ‘fatty liver disease,’ (MASLD) found that semaglutide was highly effective at reducing liver fat and cardiovascular disease risk in...
23-Apr-2024 2:00 PM EDT
Add to Favorites